









Mercado
/
Acciones
/
nasdaq-gkos
/

Glaukos Corp

GKOS

88.350USD

+4.490+5.35%

Cierre 11/10, 16:00（ET）Cotizaciones retrasadas 15 min

5.07BCap. mercado

PérdidaP/E TTM



Glaukos Corp

88.350

+4.490+5.35%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Glaukos Corp Compañía

Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. It develops novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders and retinal disease. Its product candidates include Micro-Invasive Glaucoma Surgery products that involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma and procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time. Its products include transdermal pharmaceuticals that are applied to the eyelid and designed to treat glaucoma, dry eye, presbyopia and other ocular surface diseases and disorders and micro-invasive, bio-erodible sustained release drug delivery implants to improve the vision of patients.

Información de Glaukos Corp



Símbolo de cotizaciónGKOS

Nombre de la empresaGlaukos Corp

Fecha de salida a bolsaJun 25, 2015

Director ejecutivoMr. Thomas William Burns

Número de empleados995

Tipo de seguridadOrdinary Share

Fin del año fiscalJun 25

Dirección1 Glaukos Way

CiudadALISO VIEJO

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal92656

Teléfono19493679600

Sitio Webhttps://www.glaukos.com

Símbolo de cotizaciónGKOS

Fecha de salida a bolsaJun 25, 2015

Director ejecutivoMr. Thomas William Burns

Ejecutivos de Glaukos Corp



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.51M

+0.69%

Mr. David F. Hoffmeister

Independent Director

69.52K

+56.16%

Mr. Mark J. Foley

Lead Independent Director

56.36K

+3.89%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.23K

+4.47%

Mr. Marc A. Stapley

Independent Director

36.18K

+6.19%

Dr. Tomas Navratil

Chief Development Officer

33.32K

-12.37%

Dr. Leana S. Wen, M.D.

Independent Director

Dr. Gilbert H. (Gil) Kliman, M.D.

Independent Director

Ms. Denice M. Torres, J.D.

Independent Director

Mr. Joseph E. Gilliam

President, Chief Operating Officer

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.51M

+0.69%

Mr. David F. Hoffmeister

Independent Director

69.52K

+56.16%

Mr. Mark J. Foley

Lead Independent Director

56.36K

+3.89%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.23K

+4.47%

Mr. Marc A. Stapley

Independent Director

36.18K

+6.19%

Dr. Tomas Navratil

Chief Development Officer

33.32K

-12.37%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

Glaucoma

103.53M

83.41%

Corneal Health

20.59M

16.59%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

90.52M

72.93%

International

33.60M

27.07%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Glaucoma

103.53M

83.41%

Corneal Health

20.59M

16.59%

Estadísticas de accionistas

Actualizado: sáb., 16 de ago

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

13.75%

The Vanguard Group, Inc.

10.50%

Fidelity Management & Research Company LLC

9.12%

Wellington Management Company, LLP

5.65%

State Street Investment Management (US)

3.64%

Otro

57.34%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

13.75%

The Vanguard Group, Inc.

10.50%

Fidelity Management & Research Company LLC

9.12%

Wellington Management Company, LLP

5.65%

State Street Investment Management (US)

3.64%

Otro

57.34%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

56.75%

Investment Advisor/Hedge Fund

34.75%

Hedge Fund

9.08%

Individual Investor

3.32%

Pension Fund

2.06%

Research Firm

1.76%

Sovereign Wealth Fund

1.32%

Bank and Trust

1.12%

Family Office

0.04%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

653

61.34M

106.80%

+235.97K

2025Q2

638

61.06M

106.48%

+15.37K

2025Q1

643

60.20M

105.40%

-1.30M

2024Q4

610

59.75M

105.65%

+533.86K

2024Q3

567

57.47M

104.31%

-894.95K

2024Q2

545

56.86M

103.79%

-713.22K

2024Q1

509

54.47M

110.12%

-1.91M

2023Q4

480

53.71M

109.34%

-1.79M

2023Q3

475

52.90M

108.58%

-1.85M

2023Q2

486

51.69M

106.83%

-2.99M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

7.90M

13.77%

+252.68K

+3.31%

Jun 30, 2025

The Vanguard Group, Inc.

6.10M

10.63%

+146.00K

+2.45%

Jun 30, 2025

Fidelity Management & Research Company LLC

5.24M

9.14%

-327.70K

-5.89%

Jun 30, 2025

Wellington Management Company, LLP

3.24M

5.66%

+953.61K

+41.63%

Jun 30, 2025

State Street Investment Management (US)

2.09M

3.64%

+105.97K

+5.34%

Jun 30, 2025

PRIMECAP Management Company

1.83M

3.19%

+609.52K

+50.02%

Jun 30, 2025

Burns (Thomas William)

1.51M

2.63%

+10.26K

+0.69%

Sep 23, 2025

Geode Capital Management, L.L.C.

1.33M

2.32%

+115.53K

+9.51%

Jun 30, 2025

AllianceBernstein L.P.

1.25M

2.18%

-25.68K

-2.01%

Jun 30, 2025

Westfield Capital Management Company, L.P.

1.17M

2.04%

+83.67K

+7.72%

Jun 30, 2025

ETFs relacionados



Actualizado: jue., 6 de nov

Nombre

Proporción

Invesco S&P SmallCap Health Care ETF

2.97%

Alger Weatherbie Enduring Growth ETF

1.88%

SPDR S&P Health Care Equipment ETF

1.53%

ROBO Global Healthcare Technology & Innovation ETF

1.31%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.63%

SPDR S&P 600 Small Cap Growth ETF

0.63%

iShares S&P Small-Cap 600 Growth ETF

0.59%

iShares U.S. Medical Devices ETF

0.57%

SPDR S&P SmallCap 600 ESG ETF

0.46%

OneAscent Small Cap Core ETF

0.46%

Invesco S&P SmallCap Health Care ETF

Proporción2.97%

Alger Weatherbie Enduring Growth ETF

Proporción1.88%

SPDR S&P Health Care Equipment ETF

Proporción1.53%

ROBO Global Healthcare Technology & Innovation ETF

Proporción1.31%

Vanguard S&P Small-Cap 600 Growth Index Fund

Proporción0.63%

SPDR S&P 600 Small Cap Growth ETF

Proporción0.63%

iShares S&P Small-Cap 600 Growth ETF

Proporción0.59%

iShares U.S. Medical Devices ETF

Proporción0.57%

SPDR S&P SmallCap 600 ESG ETF

Proporción0.46%

OneAscent Small Cap Core ETF

Proporción0.46%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

